Virucidal effect of povidone-iodine against SARS-CoV-2 in vitro. 2021

Ying Wang, and Yutong Wu, and Qingjing Wang, and Jiajie Zhu, and Wen Shi, and Zetao Han, and Yanjun Zhang, and Keda Chen
Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Centre for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Centre of Zhejiang University, Hangzhou, Zhejiang Province, China.

OBJECTIVE To evaluate the antiviral activity of the oral disinfectant povidone-iodine (PVP-I) against severe acute respiratory syndrome-coronavirus-2 (SARS-CoV2) in vitro. METHODS The cytotoxic effects of PVP-I were determined in Vero and Calu-3 cell lines using that by Cell Counting Kit-8 assay. Viral load in the cell culture medium above infected cells was quantitated using real-time polymerase chain reaction. The cytopathic effect (CPE) and viral infective rate were observed by immunofluorescence microscopy. RESULTS PVP-I at a concentration >0.5 mg/ml in contact with SARS-CoV-2 for 30 s, 1 min, 2 min and 5 min showed up to 99% viral inhibition. For in vitro testing, upon exposure for 1 min, PVP-I showed a virucidal effect. PVP-I had no cytotoxic effects at the range of concentrations tested (0.125-1 mg/ml; CC50 > 2.75 mM) in Vero and Calu-3 cells. CONCLUSIONS These results demonstrate that the ideal contact time was 1 min and the optimal concentration was 1 mg/ml, which provides an experimental basis for the use of oral disinfectants in dental hospitals.

UI MeSH Term Description Entries
D011206 Povidone-Iodine An iodinated polyvinyl polymer used as topical antiseptic in surgery and for skin and mucous membrane infections, also as aerosol. The iodine may be radiolabeled for research purposes. PVP-Iodine,Polyvinylpyrrolidone Iodine,Alphadine,Betadine,Betaisodona,Disadine,Isodine,PVP-I,Pharmadine,Providine,Alphadines,Betadines,Disadines,Isodines,PVP Iodine,PVP-Iodines,Pharmadines,Polyvinylpyrrolidone Iodines,Povidone Iodine,Povidone-Iodines,Providines
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA

Related Publications

Ying Wang, and Yutong Wu, and Qingjing Wang, and Jiajie Zhu, and Wen Shi, and Zetao Han, and Yanjun Zhang, and Keda Chen
December 2020, British dental journal,
Ying Wang, and Yutong Wu, and Qingjing Wang, and Jiajie Zhu, and Wen Shi, and Zetao Han, and Yanjun Zhang, and Keda Chen
September 2020, Infectious diseases and therapy,
Ying Wang, and Yutong Wu, and Qingjing Wang, and Jiajie Zhu, and Wen Shi, and Zetao Han, and Yanjun Zhang, and Keda Chen
October 2022, Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India,
Ying Wang, and Yutong Wu, and Qingjing Wang, and Jiajie Zhu, and Wen Shi, and Zetao Han, and Yanjun Zhang, and Keda Chen
February 2022, Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995),
Ying Wang, and Yutong Wu, and Qingjing Wang, and Jiajie Zhu, and Wen Shi, and Zetao Han, and Yanjun Zhang, and Keda Chen
February 2022, BMC oral health,
Ying Wang, and Yutong Wu, and Qingjing Wang, and Jiajie Zhu, and Wen Shi, and Zetao Han, and Yanjun Zhang, and Keda Chen
July 2021, Journal of oral and maxillofacial surgery, medicine, and pathology,
Ying Wang, and Yutong Wu, and Qingjing Wang, and Jiajie Zhu, and Wen Shi, and Zetao Han, and Yanjun Zhang, and Keda Chen
April 2022, Oral diseases,
Ying Wang, and Yutong Wu, and Qingjing Wang, and Jiajie Zhu, and Wen Shi, and Zetao Han, and Yanjun Zhang, and Keda Chen
September 2021, The journal of evidence-based dental practice,
Ying Wang, and Yutong Wu, and Qingjing Wang, and Jiajie Zhu, and Wen Shi, and Zetao Han, and Yanjun Zhang, and Keda Chen
July 2021, Antiviral research,
Ying Wang, and Yutong Wu, and Qingjing Wang, and Jiajie Zhu, and Wen Shi, and Zetao Han, and Yanjun Zhang, and Keda Chen
July 2021, Future microbiology,
Copied contents to your clipboard!